About Klinikum Bielefeld Rosenhoehe
"Das Klinikum Rosenhöhe ist ein Standort des Klinikums Bielefeld. Hier bieten wir unseren Patientinnen und Patienten eine ausgezeichnete medizinische Leistungsfähigkeit. An unseren drei Standorten Klinikum Bielefeld Mitte, Klinikum Bielefeld Rosenhöhe und Klinikum Bielefeld – Halle/Westf. werden pro Jahr mehr als 140.000 Patienten und Patientinnen (Jahr 2019) versorgt. Das Klinikum gliedert sich in 30 Fachkliniken und Institute und bietet Platz für bis zu 1.100 Patientinnen und Patienten. Wir sind mit über 3.000 Mitarbeiterinnen und Mitarbeitern 24 Stunden am Tag an 7 Tagen die Woche für Sie da. Durch all diese Faktoren genießt das Klinikum Bielefeld in der Bevölkerung der Region Ostwestfalen-Lippe ein hohes und stetig steigendes Ansehen."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
4
Janssen-Cilag G.m.b.H
1
Clinical Trials at Klinikum Bielefeld Rosenhoehe
During the past decade, Klinikum Bielefeld Rosenhoehe conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on
average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
2018-03-08
2025-06-30
Active, not recruiting
3,163
Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring Subjects
2018-06-11
2020-10-07
Completed
1,235
Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy
2018-10-29
2020-03-06
Completed
838
A Study to Evaluate Further Therapeutic Strategies With Guselkumab in Participants With Moderate-to-Severe Plaque-Type Psoriasis
2019-02-08
2025-01-30
Active, not recruiting
880
Study of Abrocitinib Compared With Dupilumab in Adults With Moderate to Severe Atopic Dermatitis on Background Topical Therapy
2020-06-11
2021-07-13
Completed
727
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Klinikum Bielefeld Rosenhoehe
According to Clinical.Site data, the most researched conditions in "Klinikum Bielefeld Rosenhoehe" are
"Dermatitis, Atopic" (3 trials), "Dermatitis" (2 trials), "Eczema" (2 trials), "Genetic Diseases, Inborn" (2 trials) and "Hypersensitivity" (2 trials). Many other conditions were trialed in "Klinikum Bielefeld Rosenhoehe" in a lesser frequency.
Clinical Trials Intervention Types at Klinikum Bielefeld Rosenhoehe
Most popular intervention types in "Klinikum Bielefeld Rosenhoehe" are "Drug" (5 trials) and "Combination Product" (1 trials). Other intervention types were less common.
The name of intervention was led by "Abrocitinib 200 mg" (2 trials), "PF-04965842 100 mg" (2 trials), "PF-04965842 200 mg" (2 trials), "Placebo" (2 trials) and "Abrocitinib 100 mg" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Klinikum Bielefeld Rosenhoehe
The vast majority of trials in "Klinikum Bielefeld Rosenhoehe" are
5 trials for "All" genders.
Clinical Trials Status at Klinikum Bielefeld Rosenhoehe
Currently, there are NaN active trials in "Klinikum Bielefeld Rosenhoehe".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Klinikum Bielefeld Rosenhoehe,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Klinikum Bielefeld Rosenhoehe, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".